pharma 1 1

Tag: "pharma" at medical news

Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched

...vely expensive.However in the past few years other pharma companies have been allowed to manufacture the drug giving Novartis a competetion. The current tablet size are big and makes it uncomfortable to swallow. The pharmaceutical company SangStat expects to launch significantly smaller cyclosporine caps...

Now AIDS treatment comes dirt-cheap

... After waging wars over many drug formulations the pharma majors are now locking horns over AIDS treatment. The ball was set in motion by the dramatic announcement of Indian firm Cipla that a three-drug combination for AIDS treatment would cost less than a U.S. dollar a day. Not to be left far behind rival ...

Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos

...acility and also to take up joint initiatives with pharma majors like the above, he said. Various studies and forecasts made on AIDS in India warn of an epidemic with infection numbers being put at nearly 40 lakh at present. With the costs of the few available anti-AIDS drugs still very much beyond the aff...

Pharma cos must forge Strategic alliances

...oiletries and agarbattis. He said that the Indian pharma industry was one of the dynamic industries as its products was comparable with global products in terms of safety, efficacy and quality with 400 different drugs and 2,000 formulation. Mr. Chokani hoped that the new branch in Delhi would act as an ef...

Setting up a new pharmaceutical industry in India

...azil. As India has a high potential and the Indian pharma industry is poised to take a big leap. Already all major pharmaceutical companies in India has started giving more attention towards basic product R&D and are going to need most accurate, proven and highly advance equipment. The Indian operation is...

Pharma majors gear to supply anti-anthrax drug

...profloxacin. Already there is news that the German pharma major Bayer is tripling its production of Ciprofloxacin to cater to the burgeoning demand and will supply 200 million tablets in the next three months. In fact, Bayer holds the U.S. patents on the most common forms of Ciprofloxacin and these expire o...

Pharmacies in for a dose of bitter medicine

...s patients' health, it also dulls job prospects of pharma graduates....

Morepan to file new drug applications with the USFDA

Domestic pharma major Morepen Labs is planning to file its nine abbreviated new drug applications (ANDA) with the US FDA by the year 2003. The company would file its first two ANDAs - Loratadine (anthistatminic drug) and Atorvastain Calcium (anti-cholesterol) - by t...

Nicholas buys ICI’s drug business for Rs 70 c

...er one player in the cardiovascular segment. ICI’s pharma sales amounted to Rs 69 crore in 2000-2001. This i...any, vaulting it into the league of Rs 1,000-crore pharma firms.The acquisition of the ICI business brings with it key brands in the cardiovascular segment, s...

Myth of 'female impotence' created to boost sales

...t a group of researchers in close conjunction with pharma companies sponsoring meetings are defining a new c.... However, a spokeswoman for one of the leading pharma companies denies such reports stating, "We work on unmet medical needs. There were academics who wer...

High development costs hinder entry of cancer super drugs into the market

... this requires sophisticated screening tests. The pharma companies are already pulling out of oncology drugs since the potential market is too small, as the patients treated with a particular drug are confined to a small genetically defined subgroup, and the sales from this small group would not cover the ...

Indian pharma industry upbeat on WTO drug deal

...ut any pre-conditions,'' a spokesman from domestic pharma major Ranbaxy Labs told UNI here. Terming it as a positive development, he said the pact will benefit both the needy nations and the producers of such drugs. Sanat Products Ltd CEO Manoj Pahwa described it a gain for India. ''Besides benefitting us...

The Use of Radio Frequency Identification ( RFID) to tackle the growing menace of counterfeit drugs

...rna of Indian Institute of Packaging says although pharma companies are trying to bring in novel features to...falling into the hands of counterfeiters. Indian pharma companies should look at RFID soon for detection of counterfeit merchandise, product recall, arresti...

Clampdown On Fake Drugs Manufacturers In India – New Bill Enacte

...rnment is only protecting the interests of the big pharma by bringing in trademark offences under the spurious drug bill and that if the government was really serious about knowing the exact magnitude of spurious drug manufacturing, they would have ordered for the national survey which was recommended by th...

New Bioinformatics Centre to open in Andhra

...telemedicine utility to network with hospitals and pharma companies to accelerate the process of drug discovery. It would network with 12 other centres of excellence in biology created by Sun all over the world. "As a Sun centre of excellence, CDFD joins Sun's community of research institutions developing...

Fight against Fungus - A new ray of hope

...g called caspofungin, which is manufactured by the pharma major Merck. The study, which was funded by Merck involved testing both the new drug and old ones in nearly 250 patients from around the world. The study concluded that the new drug, caspofungin was as effective as Amphotericin B without as many sid...

Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib

Indian Pharmaceuticals companies Glenmark pharma and Nicholas Piramal has withdrawn their drug Vald...lth ministry of the government of India asking the pharma companies to stop selling and production of Valdecoxib. Ranbaxy as already withdrew the drug from th...

Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies

...hese reasons these companies are considering a big pharma buy out. This year lot of companies have choose acquisition – San Diego based Idun Pharmaceutical and Syrix Pharmaceuticals (Pfizer), TransForm Pharmaceuticals and NeoGenesis, both located outside Botson (Johnson & Johnson and Scherring-Plough). ...

Abbott’s Laboratories R&D Capabilities Questione

...sses and how successful they are compared to their pharma peers. They're definitely on the lower end. Glenn Novarro analyst in Banc of America Securities is optimistic about R&D of Abbott and said that though Xinlay may be a failure its other products in the pipeline like drugs Humira, Simdax, Febuxostat,...

India to maintain Public domain Registry database of clinical trials conducted in India.

...n methods employed in high-risk clinical trials by pharma firms and the concern on outsourcing of such trials to developing countries. The speakers at the inaugural session underlined the need for a strong legislative and regulatory framework for clinical trials and addressing ethical issues. Experts View...

1 2 3 4 5